S

Saravanan

Active Director Director DIN 02972417
DIN 02972417 First appointment Apr 2010 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 2010
Shareholding value Locked Premium profile

About Saravanan

Saravanan has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Maxell Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02972417
Primary Designation Director
First Appointment 16 Apr 2010
Oldest Company Age 16 yrs

Current companies

Company Designation Appointment Founded Status
Maxell Pharma Private Limited U24297TN2010PTC075380
Director 16 Apr 2010 2010 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maxell Pharma Private Limited
Premium access

Shareholding and investment profile for Saravanan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saravanan

Saravanan has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Maxell Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Saravanan is associated with 1 company as Director.

Saravanan has expertise in General Business.

Saravanan has 16 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available